江苏扬农化工股份有限公司 累积投票制实施细则 江苏扬农化工股份有限公司 （草案） 第一条 为了进一步完善公司法人治理结构，保证股东充分行使权利，根据 中国证监会《上市公司治理准则》《上海证券交易所上市公司自律监管指引第 1 号——规范运作》的要求及《公司章程》的规定，特制订本实施细则。 第二条 本实施细则所指的累积投票制，是指股东会选举董事时，每一股份 拥有与应选董事人数相同的表决权，股东拥有的表决权可以集中使用。 第三条 公司股东会在选举两名以上董事时，股东所持有的每一股都拥有与 应选董事总人数相等的投票权，股东既可以用所有的投票权集中选举一人，也可 以分散选举数人，按得票多少依次决定当选董事。 第四条 股东会以累积投票方式选举董事的，独立董事和非独立董事的表决 应当分别进行，并根据应选董事人数，按照获得的选举票数由多到少的顺序确定 当选董事。 具体操作如下： （四）表决完毕后，由股东会监票人清点票数，并公布每个董事候选人的得 票情况。依照各议案组董事候选人所得票数多少，决定该议案组董事人数，当选 董事所得的票数必须超过出席该次股东会股东所持表决权的二分之一。 （五）如果根据（四）之规定，在股东会上各议案组 ...

江苏扬农化工股份有限公司 董事、高级管理人员持有及买卖本公司股票管理制度 江苏扬农化工股份有限公司 董事、高级管理人员 持有及买卖本公司股票管理制度 （草案） 《上海证券交易所上市公司自律监管指引第 15 号——股 东及董事、高级管理人员减持股份》等法律法规和中国证监会、上海证券交易所 的有关规定，制定本制度。 第二条 本制度适用于公司董事、高级管理人员所持本公司股份及其变动的 管理。 公司董事、高级管理人员所持本公司股份，是指登记在其名下和利用他人账 户持有的所有本公司股份。 公司董事、高级管理人员从事融资融券交易的，其所持本公司股份还包括记 载在其信用账户内的本公司股份。 董事、高级管理人员不得融券卖出本公司股份。 第三条 公司董事、高级管理人员不得开展以本公司股票为合约标的物的衍 生品交易。 第四条 公司董事会秘书负责管理公司董事和高级管理人员的身份及所持 本公司股份的数据，统一为董事和高级管理人员办理个人信息的网上申报，每季 度检查董事和高级管理人员买卖本公司股票的披露情况。 第五条 董事、高级管理人员应当主动配合公司的管理工作，如实申报持有 及买卖本公司股票的情况，杜绝出借帐户的行为。 （2008 ...

Core Viewpoint - Jiangsu Yangnong Chemical Co., Ltd. reported a revenue increase of 9.38% year-on-year for the first half of 2025, despite facing challenges in the agricultural chemical industry due to global economic conditions and trade tensions [2][8]. Company Overview and Financial Indicators - The company achieved an operating income of CNY 6.23 billion, up from CNY 5.70 billion in the same period last year [2][8]. - The total profit for the period was CNY 952.97 million, a 7.26% increase from CNY 888.44 million [2][8]. - Net profit attributable to shareholders was CNY 805.86 million, reflecting a 5.60% increase compared to CNY 763.11 million [2][8]. - The net cash flow from operating activities decreased by 34.34% to CNY 1.73 billion [2][8]. - The company's total assets reached CNY 18.24 billion, a 3.24% increase from the previous year [2][8]. Industry Context - The agricultural chemical industry is facing multiple challenges, including weakened global economic growth, trade protectionism, and geopolitical risks, which have impacted market demand [3][4]. - Despite these challenges, there are structural opportunities driven by the strategic importance of food security and government policies supporting agricultural development [5][8]. - The domestic pesticide market is experiencing increased supply due to new production capacities, while global food prices remain low, affecting pesticide demand [4][5]. Business Operations - The company focuses on the research, production, and sales of pesticide products, with a diverse product range including insecticides, herbicides, and fungicides [7][8]. - The first half of the year is typically the peak season for pesticide sales, with a significant portion of revenue generated during this period [7][8]. - The company has implemented strategies to adapt to market conditions, including expanding into new regional markets and enhancing production efficiency [8][9]. Competitive Advantages - Jiangsu Yangnong Chemical is recognized as a leading high-tech enterprise in the agricultural chemical sector, with a strong focus on innovation and sustainable practices [11][12]. - The company has developed a robust brand presence and maintains significant market share in both domestic and Southeast Asian markets [13][12]. - The company emphasizes technological innovation and operational excellence, which are critical for maintaining competitive advantages in a challenging market environment [11][12].

Group 1 - Glyphosate concept stocks increased by 2.03%, ranking 4th among concept sectors, with 15 stocks rising, led by Jiangtian Chemical, Yangnong Chemical, and Yingtai Biological, which rose by 10.47%, 5.33%, and 3.40% respectively [1] - The main funds net inflow into the glyphosate concept sector was 47 million yuan, with 8 stocks receiving net inflows, and 5 stocks seeing inflows exceeding 10 million yuan, led by Noposion with a net inflow of 38.12 million yuan [2] - The top three stocks by net inflow ratio were Taihe Co., Ltd., Lier Chemical, and Noposion, with net inflow ratios of 8.33%, 5.80%, and 5.40% respectively [3] Group 2 - The glyphosate concept stocks' performance included Noposion with a 2.61% increase, Jiangtian Chemical with a 10.47% increase, and Lier Chemical with a 2.12% increase, among others [3] - The overall market performance showed that the glyphosate concept was among the top gainers, indicating positive market sentiment towards this sector [2]

农药分为创新药和仿制药，少数拥有创新能力的跨国巨头掌握着产业链高附加值环节 搭建农药创新药研发平台的底层逻辑在于构建一个以数据为驱动、模型为支撑、算法为引擎的系统，实 现从靶标发现到候选分子筛选、优化与评估的全流程智能化。在构建模型方面，Kruger等人(2023)提出 了一个基于机器学习判断化合物是否具有杀虫活性的典型数据筛选案例，其通过构建杀虫剂与非杀虫剂 样本的数据集，训练机器学习模型以识别潜在杀虫剂分子，并依据特征数据进行性能评估。在优化模型 方面，Chen等(2023)提出Pesti-DGI-Net深度学习结构，该架构通过多模态机器学习手段优化农药识别模 型。考虑到当前许多成熟的机器学习模型辅助药物研发工具主要针对药品单一属性，构建综合性工具平 台是AI辅助农药创新药研发较为实用的解决方案。例如，PDAI平台(Pesticide Designbasedon Artificial Intelligence)就是一个专门为农药分子设计量身打造的综合性开发平台，通过整合多种技术模块，覆盖 从靶点识别到候选物筛选等多个关键研发阶段，为农药研发提供一站式服务。 农药是用于防治农林业病虫害以及调节植物生长的各种 ...

Group 1 - The company proposes to provide a guarantee of up to RMB 2 billion for its wholly-owned subsidiary, Anhui Dongzhi Guangxin Agricultural Chemical Co., Ltd., to support its daily operations and business development [1] - The board of directors has approved the proposal to cancel the supervisory board, transferring its powers to the audit committee of the board, in accordance with the latest regulations [1][3] - The company plans to revise certain corporate governance systems to enhance internal governance mechanisms, aligning with the latest rules and regulations from the Shanghai Stock Exchange [3] Group 2 - The general meeting is scheduled for September 4, 2025, with provisions for both on-site and online voting [2] - The meeting will include the introduction of participants, discussion of agenda items, and the announcement of voting results [2]

Market Overview - The Shanghai Composite Index rose by 0.13%, reaching a ten-year high, while high-position stocks continued to decline [1] - The stablecoin concept showed strong performance throughout the day [1] Companies and Innovations - Cross-border e-commerce leader, Kuaibao, may benefit from stablecoins by providing faster transaction speeds and reducing settlement costs [3] - Kunsun Bank, a subsidiary of Zhongyou Capital, is the only official bank for international settlements between China and Iran, and is involved in digital RMB payment business [3] - Huike Rongtong, a subsidiary of Cuiwei Co., has integrated with the central bank's digital currency research institute to support digital RMB payment services [3] - The company, Jingbeifang, is collaborating with Guofu Quantum to explore blockchain, AI, big data, and other technologies for stablecoin operations [3] - Yushun Technology is set to unveil a new humanoid robot product [5] - Dayong Co. has developed a new type of high-voltage and high-current connector for applications in new energy vehicles and 5G communications [7] Industry Developments - The State Council is accelerating the cultivation of service consumption and new consumption growth points [3] - The Ministry of Industry and Information Technology held a meeting on the photovoltaic industry [6] - The company, Zangzhou Development, is increasing investments in photovoltaic projects, with a cumulative installed capacity of approximately 30 MW [6] Financial Performance - Xilinmen, a leading mattress company in China, reported a 22.43% year-on-year increase in net profit for the mid-year report [6] - The market transaction volume has consistently exceeded 2 trillion, with the Shanghai Composite Index reaching a nearly ten-year high [7]

Core Viewpoint - Limin Co., Ltd. achieved a net profit attributable to shareholders of 269 million yuan in the first half of the year, representing a year-on-year increase of 747.13% [1] Financial Performance - In Q2, the company realized a net profit attributable to shareholders of 161 million yuan, showing a year-on-year growth of 299.54% and a quarter-on-quarter increase of 48.66% [1] - The company's performance for the first half of 2025 is expected to continue growing at a rate of 747% year-on-year [1] Market Position and Strategy - The company has further solidified its position as a leading domestic pesticide manufacturer, focusing on technological innovation, global expansion, and green transformation [1] - There has been a continuous increase in market share, with major product prices and sales volumes rising year-on-year, alongside an improvement in gross profit margins [1] Research and Development - The company's technical research and development capabilities have been steadily enhanced, with progress in the chemical synthesis creation plan and successful collaboration with BASF on innovative drug development [1] - Product planning is being systematically developed, with improvements in formulation research and solid advancements in biological synthesis research [1] Market Outlook - The second half of the year marks the peak sales season in the South American market, with expected strong demand for fungicide products such as mancozeb and chlorothalonil, which will support continued market growth [1]

Core Viewpoint - The company, Beishimei, reported strong financial performance in the first half of 2025, driven by its robust market competitiveness in the environmentally friendly pesticide sector and strategic expansion into new materials [1][2]. Financial Performance - In the first half of 2025, Beishimei achieved revenue of 776 million yuan, a year-on-year increase of 16.57% [1] - The net profit attributable to shareholders reached 34.71 million yuan, up 109.70% year-on-year [1] - The basic earnings per share were 0.1 yuan, reflecting a 100.00% increase compared to the previous year [1] Industry Trends - The Chinese pesticide market is projected to reach 450 billion yuan in 2024 and exceed 480 billion yuan in 2025, with a compound annual growth rate (CAGR) of 6.5% [2] - The demand for efficient, safe, and environmentally friendly pesticide products is increasing, driven by agricultural modernization and green development initiatives [2] Product and Technology Development - Beishimei has established a complete industrial chain for its self-produced pesticides, covering intermediates, active ingredients, and formulations [2] - The company holds 62 authorized patents, including 33 invention patents, emphasizing its commitment to technological innovation [4] - The purity of its active ingredient, dimethenamid-P, exceeds 98%, surpassing domestic industry standards [4] Strategic Initiatives - Beishimei is implementing a strong chain and supplement strategy, focusing on the production of key intermediates and raw materials to ensure quality and cost control [3] - The company has launched a project to produce 8,500 tons of ketone series green materials, enhancing its position in the carbon five materials sector [8] International Expansion - Beishimei's subsidiary, Ningbo Jielike, has established a sales network in 79 countries, significantly contributing to the company's overseas revenue, which reached 571 million yuan in the first half of 2025 [6] - The company’s export volume of herbicides increased by 11.11% year-on-year, indicating strong growth in international markets [5] New Materials Strategy - The carbon five series products generated revenue of 61.24 million yuan, a year-on-year increase of 141.83%, highlighting the growth potential in this segment [7] - Beishimei is focusing on the development of high-end carbon five products to capture the import substitution opportunities in the market [7][8]

Core Viewpoint - The successful bankruptcy restructuring of Nanjing Hongtaiyang Co., Ltd. is highlighted as a significant case following the release of the new "National Nine Articles" policy, showcasing the role of China Great Wall Asset Management in supporting the real economy and facilitating high-quality economic development [1][2]. Group 1: Bankruptcy Restructuring Case - Nanjing Hongtaiyang is a leading listed company in the green pesticide and "three medicines" intermediate sector, which faced a debt crisis starting in 2019 due to multiple factors [1]. - The company entered pre-restructuring in November 2022, and by September 2024, it officially entered bankruptcy restructuring after approval from the Supreme People's Court and the China Securities Regulatory Commission [1]. - The restructuring plan was approved by creditors just two months later, and the execution was completed in December of the same year, marking a rapid turnaround in the bankruptcy process [1]. Group 2: Role of China Great Wall Asset Management - China Great Wall Asset Management's Jiangsu branch effectively managed non-performing assets by acquiring bad debt packages from banks and implementing a combination of repayment strategies [2]. - The innovative "cash repayment + stock distribution" plan helped stabilize the employment of nearly 10,000 employees and protect the rights of over 300 creditors and 20,400 small shareholders [2]. - The restructuring led to the systematic resolution of Nanjing Hongtaiyang's debt, which amounted to 14.1 billion yuan, restoring the company's operational capabilities [2].